Efficacy of Combination Sofosbuvir, Pegylated-Interferon, and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 Infection in Indonesia

Efficacy of Combination Sofosbuvir, Pegylated-Interferon, and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 Infection in Indonesia

Background: The presence of direct-acting antiviral (DAA) has improved the treatment of HCV infection and making it more preferable than Pegylated-interferon (PegIFN) and Ribavirin (RBV) based treatment. However, treatment with all DAA combination regimen is limited and expensive in low health care...

Full description

Bibliographic Details
Main Authors: Andri Sanityoso Sulaiman, Rino Alvani Gani, Irsan Hasan, Cosmas Rinaldi A Lesmana, Juferdy Kurniawan, Chyntia Olivia Maurine Jasirwan, Kemal Fariz Kalista, Muhammad Yusuf Hanif
Format: Article
Language:English
Published: Interna Publishing 2018-08-01
Series:The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Subjects:
direct-acting antiviral
hepatitis C
sofosbuvir
ribavirin
interferon
Online Access:http://ina-jghe.com/journal/index.php/jghe/article/view/665/539

Internet

http://ina-jghe.com/journal/index.php/jghe/article/view/665/539

Similar Items